Overview

A First-in-human Study of YN001 in Healthy Volunteers

Status:
Not yet recruiting
Trial end date:
2023-06-27
Target enrollment:
Participant gender:
Summary
This will be a single center, randomized, double-blind, placebo-controlled, single ascending dose study in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Beijing Inno Medicine Co., Ltd.